Results of mass screening for neuroblastoma in 18-month-old infants in Osaka area, Japan
ConclusionThe 18MS did not screen unfavorable cases with neuroblastoma efficiently, although few participants benefited from it.
Source: Pediatric Surgery International - Category: Surgery Source Type: research
More News: Brain | Children | Japan Health | Neuroblastoma | Neurology | Neurosurgery | Pediatrics | Surgery | Women